NL-OMON34696尚未招募3 期
The Global randomized NBi bladder cancer study A Multi-Centre, International study to compare the use of Narrow Band Imaging (NBI) versus White light (WL) to assess recurrence of bladder cancer in terms of safety and efficacy. - NBI vs White light TURB
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients scheduled for treatment of a primary/recurrent NMIBC
- •Patients should be aged 18 years or older
- •No tumours in the upper urinary tract
- •No previous irradiation of the pelvis
排除标准
- •Gross hematuria at the time of TURB. (Note: Gross hematuria is defined as a heavy bladder bleeding resulting in marked amounts of blood in the urine, which may interfere with cystoscopy).
- •Participation in other clinical studies with investigational drugs either concurrently or within the last 30 days.
- •* Pregnant (all women of child-bearing potential must document a negative serum or urine pregnancy test at screening and use the contraceptive pill or intrauterine device (IUD) during the treatments and for at least one month thereafter).
研究者
相似试验
进行中（未招募）
不适用
First international Inter-Group Study for nodular lymphocyte-predominant Hodgkin’s Lymphoma in Children and AdolescentsEarly stage nodular lymphocyte predominant Hodgkin's lymphoma [nLPHL]MedDRA version: 14.0Level: PTClassification code 10029602Term: Non-Hodgkin's lymphoma stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-004092-19-GBMartin Luther University of Halle/Wittenberg250
进行中（未招募）
1 期
First international Inter-Group Study for nodular lymphocyte predominantHodgkin`s Lymphoma in Children and AdolescentsEUCTR2007-004092-19-FRMartin Luther University of Halle/Wittenberg200
已完成
不适用
A Randomised, Open-label, Phase III Study of BIBW 2992 Versus Chemotherapy as First-line Treatment for Patients With Stage IIIB or IV Adenocarcinoma of the Lung Harbouring an EGFR Activating Mutatio-C34 Malignant neoplasm of bronchus and lungMalignant neoplasm of bronchus and lungC34PER-115-09Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI),7
进行中（未招募）
1 期
Open-label, randomised trial to evaluate the efficacy and safety of MOR00208 with bendamustine versus rituximab with bendamustine in adult patients with a cancer of B cells, a type of white blood cell responsible for producing antibodies, which has returned after a period of improvement or that has proved resistant, or does not respond to, treatmentEUCTR2014-004689-11-ROMorphoSys AG330
进行中（未招募）
1 期
Open-label, randomised trial to evaluate the efficacy and safety of MOR00208 with bendamustine versus rituximab with bendamustine in adult patients with a cancer of B cells, a type of white blood cell responsible for producing antibodies, which has returned after a period of improvement or that has proved resistant, or does not respond to, treatmentEUCTR2014-004689-11-CZMorphoSys AG330